Cong Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cong Wu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Benzhong Zhang
School of Public Health, Lanzhou University, Lanzhou, Gansu, China
2 shared publications Wenhua He
School of Public Health, Lanzhou University, Lanzhou, China
2 shared publications- Xiaoling Gao
The Clinical Laboratory Center, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China
2 shared publications Xiaoxia Wang
School of Public Health, Lanzhou University, Lanzhou, China
2 shared publications- Yanjuan Jia
The Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital, Lanzhou, China
2 shared publications Yonghong Li
The Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital, Lanzhou, China
2 shared publications
Latest Publications
- Open Access
- 1 October 2019
- Published by Elsevier in Cellular Immunology
- Vol. 344, 103947
DosR antigen Rv1737c induces activation of macrophages dependent on the TLR2 pathway
- 1 October 2019
- Published by Elsevier in Cellular Immunology
- Vol. 344, 103947
Open AccessDosR antigen Rv1737c induces activation of macrophages dependent on the TLR2 pathway
- 29 October 2018
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 89 (1) , e12729
The DosR antigen Rv1737c from Mycobacterium tuberculosis confers inflammation regulation in tuberculosis infection
There is an urgent need to identify the potential risk factors for activating latent Mycobacterium tuberculosis infection. In this study, we evaluated the immune function of Rv1737c, which is a latency‐associated antigen of dormancy survival regulator (DosR) of M. tuberculosis in a mouse model. Our data showed that mice pretreated with recombinant Rv1737c (rRv1737c) exhibited higher levels of antigen‐specific antibodies (IgG, IgM and IgA) than sham‐treated mice. Following Bacilli Calmette‐Guerin (BCG) challenge, rRv1737c adjuvanted with cholera toxin subunit B (CTB) induced diffuse lung inflammation and fibrosis compared to the control mice. The inflammatory pathogenesis due to rRv1737c pre‐exposure was associated with a switch in the macrophage phenotype from M1 to activated M2 and was characterized by IL‐10 production. Intracellular cytokine analysis further showed that the rRv1737c‐pretreated mice exhibited an increased frequency of Th2 cells in the lungs, lymph nodes and spleen after BCG challenge. Furthermore, IFN‐γ expression increased in the lungs after rRv1737c pretreatment compared to that in the sham mice. Accordingly, lung cells from rRv1737c‐immunized mice stimulated with killed BCG produced higher levels of multiple cytokines, such as IFN‐γ, IL‐10 and IL‐6. The results confirmed that the pathological features of rRv1737c promoted inflammation. Overall, our findings provide direct evidence of the pro‐inflammatory function of rRv1737c in a murine model of BCG infection, indicating that Rv1737c is a pathogenic antigen of M. tuberculosis and may be key to the recurrence of latent infection.
- 29 October 2018
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 89 (1) , e12729
The DosR antigen Rv1737c from Mycobacterium tuberculosis confers inflammation regulation in tuberculosis infection
There is an urgent need to identify the potential risk factors for activating latent Mycobacterium tuberculosis infection. In this study, we evaluated the immune function of Rv1737c, which is a latency‐associated antigen of dormancy survival regulator (DosR) of M. tuberculosis in a mouse model. Our data showed that mice pretreated with recombinant Rv1737c (rRv1737c) exhibited higher levels of antigen‐specific antibodies (IgG, IgM and IgA) than sham‐treated mice. Following Bacilli Calmette‐Guerin (BCG) challenge, rRv1737c adjuvanted with cholera toxin subunit B (CTB) induced diffuse lung inflammation and fibrosis compared to the control mice. The inflammatory pathogenesis due to rRv1737c pre‐exposure was associated with a switch in the macrophage phenotype from M1 to activated M2 and was characterized by IL‐10 production. Intracellular cytokine analysis further showed that the rRv1737c‐pretreated mice exhibited an increased frequency of Th2 cells in the lungs, lymph nodes and spleen after BCG challenge. Furthermore, IFN‐γ expression increased in the lungs after rRv1737c pretreatment compared to that in the sham mice. Accordingly, lung cells from rRv1737c‐immunized mice stimulated with killed BCG produced higher levels of multiple cytokines, such as IFN‐γ, IL‐10 and IL‐6. The results confirmed that the pathological features of rRv1737c promoted inflammation. Overall, our findings provide direct evidence of the pro‐inflammatory function of rRv1737c in a murine model of BCG infection, indicating that Rv1737c is a pathogenic antigen of M. tuberculosis and may be key to the recurrence of latent infection.